Session Details
JSNM Oral 25:Brain・CNS 5: cerebrovascular and degenerative diseases
Fri. Nov 14, 2025 10:40 AM - 11:40 AM JST
Fri. Nov 14, 2025 1:40 AM - 2:40 AM UTC
Fri. Nov 14, 2025 1:40 AM - 2:40 AM UTC
Room 8（B1F, Special Exhibition Hall A, Kyoto International Exhibition Hall 'Miyako Messe'）
座長：鈴木 正彦（東京慈恵会医科大学 リハビリテーション医学講座）、岩渕 雄（慶応義塾大学医学部 放射線科学教室（診断））
[2-MO25-1]Enlargement of cerebral hypoperfusion predicts cognitive impairment:123I-IMP SPECT study
Mikio Hiura1,2,3、Muneyuki Sakata2、Shin Fukuda3、Kiyoshi Ota3、Shohei Kinoshita3、Jinichi Nunomura4、Kensyaku Tei3,5、Mikio Agata5、Yoichi Katayama1,3 (1.Research Center for Brain and Health Sciences, Aomori University, Aomori, Japan、2.TMIG Neuroimaging、3.Department of Neurosurgery, Aomori Shintoshi Hospital, Aomori, Japan、4.Department of Neurology, Aomori Shintoshi Hospital, Aomori, Japan、5.Department of Rehabilitation, Aomori Shintoshi Hospital, Aomori, Japan)
[2-MO25-2]Baseline Cerebral Blood Flow Characteristics in ADHD Comorbid Nociplastic Pain
Miwako Takahashi1、Satoshi Kasahara2、Tsutomu Soma1,3、Ko Matsudaira4、Shin-ichi Niwa5、Toshimitsu Momose6,7 (1.QST、2.Department of Anesthesiology and Pain Relief Center, The University of Tokyo Hospital, Tokyo, Japan、3.PDR、4.TMBC、5.Department of Psychiatry, Aizu Medical Center, Fukushima Medical University, Fukushima, Japan、6.Department of Biofunctional Imaging, Fukushima Medical University, Fukushima, Japan、7.The University of Tokyo, Tokyo, Japan.)
[2-MO25-3]Two Cases of Demyelinating Disease with High18F-FAZA Uptake Mimicking Brain Tumor
Kota Yokoyama1、Junichi Tsuchiya1、Jun Oyama1、Hirofumi Yamada1、Hiroya Kuwabara2、Kaoru Tamura3、Motoki Inaji3、Ukihide Tateishi1 (1.Dept. of Radiology, Inst. Sci. Tokyo、2.Dept. of Neurology, Inst. Sci. Tokyo、3.Dept. of Neurosurgery, Inst. Sci. Tokyo)
[2-MO25-4]Sympathetic MIBG index for Lewy body disease: a multi-center study
Takeshi Matsumura1、Kenichi Nakajima2、Junji Komatsu3、Satoshi Orimo4、Mitsuhiro Yoshita5、Naoki Shirasaki6、Kunihiko Yokoyama7、Moeko Shinohara3、Hiroshi Wakabayashi1、Kenjiro Ono3、Seigo Kinuya2 (1.Department of Nuclear Medicine, Kanazawa University Hospital, Ishikawa, Japan、2.Department of nuclear Medicine, Kanazawa University, Ishikawa, Japan、3.Department of Neurology, Kanazawa University, Ishikawa, Japan、4.Kamiyoga Setagaya Street Clinic, Tokyo, Japan、5.Hokuriku Hospital, Toyama, Japan、6.Kaga Medical Center, Ishikawa, Japan、7.Public Central Hosptal of Matto Ishikawa, Ishikawa, Japan)
[2-MO25-5]Discriminating BD and MDD via AMPA Receptor Imaging with [11C]K-2
Sakiko Tsugawa1,2、Yuichi Kimura3、Junichi Chikazoe4、Mai Hatano1、Waki Nakajima1、Hideaki Tani2、Hiroyuki Uchida2、Tetsu Arisawa1、Yoji Hirano5、Hirotaka Kosaka6、Takuya Takahashi1 (1.YCU. Med.、2.Keio Univ. Med.、3.Kindai Univ.、4.Hiroshima Univ. BMK Center.、5.Miyazaki Univ.、6.Fukui Univ. Med.)
[2-MO25-6]Effects of Natalizumab on Astrocyte Metabolism in Multiple Sclerosis - 11C PET study
Hiroki Kato1、Tatsusada Okuno2、Toru Koda2 (1.Department of Advanced Radioisotope Medicine, Institute for Radiation Sciences, The University of Osaka, Suita, Japan、2.Department of Neurology, The University of Osaka, Suita, Japan)